The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)

Launched by UNIVERSITY OF LUEBECK · May 23, 2022

Keywords

ClinConnect Summary

The International Subcutaneous Implantable Cardioverter Defibrillator Registry (iSuSI) is a clinical trial that focuses on understanding how well the subcutaneous implantable defibrillator (S-ICD) works for patients at risk of sudden cardiac death. This device, which is placed under the skin rather than through a vein, has been shown to have fewer complications related to its implantation compared to traditional devices. The goal of this study is to gather real-world data on the outcomes of patients who receive an S-ICD, helping doctors learn more about its effectiveness and safety.

If you are between the ages of 65 and 159 and have had an S-ICD implanted, you may be eligible to participate in this study. There are no specific exclusion criteria, so many patients could potentially join. Participants will be asked to attend follow-up appointments at least once a month after their device is implanted, either in person or through remote assessments. This is a valuable opportunity to contribute to important research that could improve care for others with similar heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Implantation of an S-ICD, regardless of the technique
• • At least 1 month of follow up
• • At least 1 post-implantation assessment, in accordance to the routine clinical practice of every center (e.g. in person visit or remote follow up)
• Exclusion Criteria:
• • - none